A descriptive study of potential sight threatening event and severe visual loss following exposure to XALKORI (crizotinib)

29/03/2016
23/04/2024
EU PAS number:
EUPAS12963
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

A8081062_FINAL_PROTOCOL_CLEAN_16MAR 2016_register

English (1.98 MB - PDF) View document
Updated protocol

A8081062_Protocol_Amendment_1 28 April 2017_EU PAS

First published: 22/02/2024
English (4.04 MB - PDF) View document
Study results
Study results

a8081062-report-body

English (5.05 MB - PDF) View document
Study report
Study report

a8081062-abstract

English (1.8 MB - PDF) View document

A8081062-first-interim-report

English (1.54 MB - PDF) View document
Other information
Study, other information

A8081062-first-interim-report.pdf

English (1.54 MB - PDF) View document